Analyst consensus rating
National Health Investors Analyst Rating: Buy
Direct answer
National Health Investors's consensus rating is Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $81.88.
Forecast evidence checked September 16, 2026.
Get free National Health Investors email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $69.30
- Average price target
- $81.88
- High price target
- $90.00
- Low price target
- $73.00
- Low target gap
- +5.3%
- Target upside
- +18.1%
- High target gap
- +29.9%
- Target range width
- 24.5%
- Consensus rating
- Buy
- Analysts
- 8
- Evidence date
- September 16, 2026
- Valid through
- September 23, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for National Health Investors?
National Health Investors has a verified Buy consensus. The same dataset has an average price target of $81.88.
How far are National Health Investors's low and high targets from the recorded price?
The low target implies +5.3%, while the high target implies +29.9%.
How many analysts are included in National Health Investors's consensus?
The verified consensus includes 8 analysts.
How is National Health Investors's target upside or downside calculated?
The average target of $81.88 is divided by the recorded price of $69.30, then one is subtracted to produce +18.1%. This does not guarantee a future return.
When was National Health Investors's analyst forecast verified?
The data was verified on 2026-09-16. The dataset is valid through 2026-09-23.